Shield Therapeutics (STX.L) Stock Price
£2.43 0%
to add to portfolio
AI Score
-
Alternative
3 -
Fundamental
2 -
Technical
4
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Shield Therapeutics, AI stock picks, stock alerts and much more.
STX.L AI Stock Analysis
AI stock analysis for STX.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Shield Therapeutics (STX.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Shield Therapeutics (STX.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Shield Therapeutics (STX.L), currently trading at £2.43, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About STX.L
-
Shield Therapeutics plc, a specialty pharmaceutical company, engages in the development and commercialization of clinical stage pharmaceuticals to treat unmet medical needs.
-
Symbol
STX.L
-
Market
LSE
-
Industry
Drug Manufacturers - Specialty & Generic
-
Market Cap
25.3M
Similar Stocks
 |
Indivior PLC INDV.L |
£1051.7 2.4% |
5 |
 |
Haleon plc HLN.L |
£383.8 0.3% |
6 |
 |
HUTCHMED (China) Limited HCM.L |
£225 2.3% |
4 |
 |
Hikma Pharmaceuticals PLC HIK.L |
£2062 0.3% |
7 |
 |
Celadon Pharmaceuticals Plc CEL.L |
£12 15% |
5 |
News
STX.L Alternative Data
Web Traffic
Shield Therapeutics receives an estimated 1640 monthly visitors to shieldtherapeutics.com.
-
Web Traffic
1640
-
Change from Previous Month
30.3%
-
3 Month Change
19.2%
-
YoY Change
19.2%
Twitter Followers
Shield Therapeutics has 618 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.5% over the last month.
-
Twitter Followers
618
-
Daily Change
0%
-
1 Month Change
0.5%
-
3 Month Change
0.6%
Job Postings
Shield Therapeutics currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
100%
LinkedIn Employees
According to LinkedIn, Shield Therapeutics has 69 employees, up by 1.5% over the last month.
-
LinkedIn Employees
69
-
Daily Change
1.5%
-
1 Month Change
1.5%
-
3 Month Change
2.8%
Business Outlook
According to employee reviews, the business outlook among employees at Shield Therapeutics is 42 out of 100 (neutral).
-
Business Outlook
42
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
News Mentions
Shield Therapeutics was mentioned 2 times in the news yesterday.
-
News Mentions
2
-
Daily Change
100%
-
1 Month Change
0%
-
3 Month Change
100%
-
YoY Change
100%
Reddit Mentions
Shield Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
1 Month Change
0%
-
3 Month Change
0%
STX.L Financials
STX.L Key Metrics
-
Total Revenue
£15.5M
-
Net Income
-£9.1M
-
Earnings per Share
-£0.0087
-
Free cash flow
-£3.7M
-
EBITDA
-£6.1M
-
EBITDA Ratio
-0.395451
-
Total Assets
£45.9M
STX.L 2-year Revenue & Income
STX.L 2-year Free Cash Flow
STX.L Technicals
STX.L SMA
STX.L RSI
FAQ
What's the current price of Shield Therapeutics (STX.L) Stock?
The price of an Shield Therapeutics (STX.L) share is £2.43.
What's the market cap of Shield Therapeutics?
The current market cap of Shield Therapeutics is 25.3M.
Should I buy or sell STX.L?
Shield Therapeutics exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.
Is Shield Therapeutics a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Shield Therapeutics stock. There are several bearish signals and market challenges that could negatively impact Shield Therapeutics' future performance, suggesting that caution should be exercised before making any investment decisions.
Is now a good time to buy Shield Therapeutics (STX.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Shield Therapeutics stock right now, as the outlook appears bearish.
What are some stocks similar to Shield Therapeutics (STX.L) that investors often compare it to?
Shield Therapeutics (STX.L) is often compared to similar stocks such as Indivior PLC, Haleon plc, HUTCHMED (China) Limited, Hikma Pharmaceuticals PLC and Celadon Pharmaceuticals Plc.
What is the forecast for Shield Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Shield Therapeutics' stock price to be around £2.2 in 2026. Starting from the current price of £2.43, this represents a 9.2% change in price, indicating a bearish outlook for the stock.
How to buy Shield Therapeutics (STX.L) Stock?
Shield Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Shield Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.